Sotera Health (NASDAQ:SHC) Price Target Cut to $12.00 by Analysts at Barclays

Sotera Health (NASDAQ:SHC) had its target price cut by Barclays from $16.00 to $12.00 in a report issued on Thursday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Barclays‘s target price suggests a potential upside of 14.27% from the stock’s previous close.

Sotera Health Price Performance

Shares of NASDAQ SHC traded down $0.82 during midday trading on Thursday, reaching $10.50. The stock had a trading volume of 208,501 shares, compared to its average volume of 1,188,505. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88. The stock has a 50-day moving average of $12.28 and a 200-day moving average of $13.61. The company has a market capitalization of $2.98 billion, a price-to-earnings ratio of 42.38 and a beta of 1.88. Sotera Health has a 12-month low of $9.53 and a 12-month high of $17.08.

Hedge Funds Weigh In On Sotera Health

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in SHC. Geode Capital Management LLC grew its position in Sotera Health by 19.4% in the third quarter. Geode Capital Management LLC now owns 2,755,391 shares of the company’s stock worth $46,026,000 after acquiring an additional 447,186 shares in the last quarter. Neo Ivy Capital Management purchased a new position in Sotera Health during the third quarter worth $720,000. Barclays PLC increased its position in Sotera Health by 169.8% during the third quarter. Barclays PLC now owns 473,597 shares of the company’s stock valued at $7,909,000 after acquiring an additional 298,085 shares during the last quarter. SG Americas Securities LLC raised its stake in shares of Sotera Health by 271.6% in the fourth quarter. SG Americas Securities LLC now owns 36,364 shares of the company’s stock valued at $497,000 after acquiring an additional 26,577 shares during the period. Finally, KBC Group NV boosted its stake in shares of Sotera Health by 4,094.6% during the 4th quarter. KBC Group NV now owns 186,365 shares of the company’s stock worth $2,549,000 after purchasing an additional 181,922 shares during the period. 91.03% of the stock is owned by institutional investors.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.